Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B-Cell Lymphoma. Biol Blood Marrow Transplant. 2014.
Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study. Blood Adv. 2021.
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group. Lancet Haematol. 2020.